About Cytiva

Cytiva supplies technologies and services that help researchers and biopharma develop and manufacture life-changing therapeutics. The company provides tools spanning laboratory research through to commercial drug manufacturing, including chromatography systems, filtration solutions, cell culture media, and bioreactors. The portfolio supports monoclonal antibodies, mRNA vaccines, viral vectors, and cell and gene therapies. With 16,000 associates across more than 40 countries and 36 global manufacturing sites, Cytiva serves academic institutions, biotech startups, and pharmaceutical companies worldwide. As part of Danaher Corporation, the company combines technical expertise with quality standards and responsive support.